Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BMS's "Information Security Department" Has Spyware for Employee Laptops
BNET Pharma
Tuesday, February 9, 2010 - 9:49am
tags:
sales reps, Bristol-Myers Squibb
Amgen Tops Novartis at Reducing Fractures in Prostate Patients
Bloomberg
Tuesday, February 9, 2010 - 9:39am
tags:
Amgen, Novartis, denosumab, prostate cancer, Zometa
Biogen Fourth-Quarter Profit Rises on Tysabri Sales
Bloomberg
Tuesday, February 9, 2010 - 9:37am
tags:
Biogen Idec, earnings, Tysabri
Dynavax starts hepatitis B trial
Bizjournals.com
Tuesday, February 9, 2010 - 9:36am
tags:
clinical trials, hepatitis B, Dynavax, Heplisav, vaccines
A Win For Crestor, AstraZeneca
Forbes
Tuesday, February 9, 2010 - 9:35am
tags:
Crestor, FDA, heart disease, AstraZeneca
Alkermes Retains Neutral Rec
Yahoo/Zacks.com
Tuesday, February 9, 2010 - 9:34am
tags:
Alkermes, Amylin, JNJ
Eli Lilly CEO’s 2009 Compensation Totaled $16.4 Million
WSJ Online
Tuesday, February 9, 2010 - 9:33am
tags:
Eli Lilly, Pharma CEOs, John Lechleiter
[video] Is Biotech Back?
Yahoo/CNBC
Monday, February 8, 2010 - 12:39pm
tags:
biotech
FDA Raises Concerns About Cell Therapeutics' Cancer Drug
TheStreet.com
Monday, February 8, 2010 - 12:38pm
tags:
Cell Therapeutics, FDA, pixantrone, lymphoma
GSK: Rare Diseases Now Big Business
WSJ Online
Monday, February 8, 2010 - 12:33pm
tags:
GSK, Prosensa, Neurosearch, JCS Pharmaceuticals, Amicus Therapeutics, Aldagen
4 Winning Biotechs For Your Portfolio: Senior Analyst
CNBC
Monday, February 8, 2010 - 12:30pm
tags:
Amgen, Gilead Sciences, Dendreon, Acorda Therapeutics
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Yahoo
Monday, February 8, 2010 - 12:27pm
tags:
Abbott Laboratories, ovarian cancer
Is The SEC Probing Trading In Dendreon?
Pharmalot
Monday, February 8, 2010 - 11:39am
tags:
SEC, Dendreon, insider trading
Teva, Active extend pact on oral MS therapy
Marketwatch
Monday, February 8, 2010 - 11:36am
tags:
Teva Pharmaceuticals, Active Biotech, partnerships, MS, multiple sclerosis
Vermont mulls free-sample disclosure rule
Fierce Pharma
Monday, February 8, 2010 - 11:35am
tags:
Vermont, samples
EU Approval for Merck's Elonva
Yahoo/AP
Monday, February 8, 2010 - 11:34am
tags:
Europe, Merck, fertility drugs, Elonva
SciClone drug sustains swine flu shot in study
Yahoo/AP
Monday, February 8, 2010 - 10:19am
tags:
SciClone, swine flu, H1N1
Broker comments lift pharma stocks
FT.com
Monday, February 8, 2010 - 10:16am
tags:
drug stocks, Teva Pharmaceuticals, GSK, Pfizer, Shire, UCB Pharmaceuticals, Merck KGaA
Eventful Year Expected for Access Pharma
Seeking Alpha
Monday, February 8, 2010 - 9:41am
tags:
Access Pharmaceuticals, cancer
Novavax, Rovi end flu-vaccine-development plan
Marketwatch
Monday, February 8, 2010 - 9:39am
tags:
Novavax, Rovi, Flu, vaccines, partnerships

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.